... according to results from the phase II TRIO-US B-12 TALENT trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, ...
News
- Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment
- Post hoc analysis paints positive picture of Trodelvy in breast cancer - The Pharma Letter
Details of the late-breaking abstract have been presented at the San Antonio Breast Cancer Symposium (SABCS). The trial is comparing Trodelvy with ...
- Caris Life Sciences to Present at the 2022 San Antonio Breast Cancer Symposium - PR Newswire
on Wednesday, December 7, from 9:45 – 11:00 a.m. CT at the 2022 SABCS in San Antonio, Texas (Presentation #HER2-12). The poster is titled "Genomic ...
- Stratus Acquires Comet Signs | citybiz
... facilities services and brand implementation services firm, today announced the acquisition of Comet Signs, based in San Antonio, Texas.
- Caris Life Sciences to Present at the 2022 San Antonio Breast Cancer Symposium
on Wednesday, December 7, from 9:45 – 11:00 a.m. CT at the 2022 SABCS in San Antonio, Texas (Presentation #HER2-12). The poster is titled "Genomic and ...